Intuity Medical partners with Embecta to promote POGO system

FREMONT, Calif., and FRANKLIN LAKES, N.J. - Sales representatives at embecta promote Intuity Medical’s POGO Automatic Blood Glucose Monitoring System to health care professionals within the U.S under a new co-promotional agreement. 

embecta, which spin off from Becton, Dickinson and Company in April, is a pure-play diabetes company with a nearly 100-year history of leadership in insulin delivery. Intuity Medical is a medical technology company focused on the development and commercialization of seamless and intuitive blood glucose monitoring solutions.   

“We are excited to partner with an established leader like embecta that has such extensive experience serving people with diabetes,” said George Zamanakos, president and CEO of Intuity Medical. “Working closely with the embecta team will help us expand where we’re able to offer POGO Automatic, giving a new option for simplifying diabetes to millions of people currently relying on conventional blood glucose meters.”  

With its 10-test cartridge technology, POGO Automatic is an automatic blood glucose monitor cleared by the U.S. Food and Drug Administration that lances, collects blood and produces a glucose result at the push of one button, ending the need to individually load and then dispose of lancets and test strips. 

Being able to offer POGO Automatic will expand the innovation and breadth of embecta’s diabetes care offerings.  

“The agreement to promote POGO Automatic to health care professionals not only enables us to expand our offerings to physicians we call on, but it does so within an innovative new category,” said Tom Blount, senior vice president and resident, North America, for embecta. “Automatic blood glucose monitoring is transforming this vital aspect of self-management into something truly seamless and simple for people with diabetes.”